基本信息:
- 专利标题: METHODS FOR CANCER TREATMENT USING STEM CELLS
- 专利标题(中):使用干细胞治疗癌症的方法
- 申请号:PCT/US2010001526 申请日:2010-05-24
- 公开(公告)号:WO2010138171A2 公开(公告)日:2010-12-02
- 发明人: IMRAN MIR
- 申请人: INCUBE LABS LLC
- 专利权人: INCUBE LABS LLC
- 当前专利权人: INCUBE LABS LLC
- 优先权: US33601210 2010-01-13; US21701109 2009-05-23
- 主分类号: A61K39/395
- IPC分类号: A61K39/395 ; A61K35/12 ; A61P35/00
摘要:
Various embodiments of the invention provide methods of treating cancer. Many embodiments provide methods of treating cancer using stem cells. In one embodiment the method comprises removing cancer cells from a patient and culturing the cancer cells in the presence of stem cells under conditions such that the stem cells differentiate into stem cell- derived cancer cells (SCDCC) which can comprise stem cell derived non-invasive and/or invasive cancer cells. An amount of the SCDCC is introduced into the patient sufficient to induce the patient's immune system to produce antibodies which inhibit or destroy the patient's cancer cells. The SCDCC may also be genetically modified to produce various immune stimulating proteins which enhance the patient's immune response to the cancer cells and improves the efficacy of the SCDNIC in treating the patient's cancer.
摘要(中):
本发明的各种实施方案提供了治疗癌症的方法。 许多实施方案提供了使用干细胞治疗癌症的方法。 在一个实施方案中,该方法包括从患者中除去癌细胞并在干细胞存在下培养癌细胞,使得干细胞分化成干细胞衍生的癌细胞(SCDCC),其可以包含干细胞来源的非侵入性 和/或浸润性癌细胞。 将足够的SCDCC量引入患者的免疫系统以产生抑制或破坏患者癌细胞的抗体。 SCDC也可以被遗传修饰以产生各种免疫刺激蛋白,增强患者对癌细胞的免疫应答,并提高SCDNIC治疗患者癌症的功效。
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61K | 医用、牙科用或梳妆用的配制品 |
------A61K39/00 | 含有抗原或抗体的医药配制品 |
--------A61K39/395 | .抗体;免疫球蛋白;免疫血清,例如抗淋巴细胞血清 |